"DYRONIB" belongs to Tyrosine Kinase Inhibitor therapy of Oncology Division. It is available in Tablet dosage form and available in three strengths : Dasatinib 20Mg Tablet, Dasatinib 50Mg Tablet and Dasatinib 70Mg Tablet.
Send us a Question
Call us to Talk
Copyright © All Rights Reserved by Azista Bhutan Healthcare Limited.